[144] Edwards Lifesciences Corp SEC Filing

Rhea-AI Filing Summary

Edwards Lifesciences reported proposed insider sales under Form 144. The filing lists multiple equity compensation-based disposals and notices of proposed sales dated 02/25/2026, 03/02/2026, and 04/02/2026 by Donald E. Bobo Jr., with share quantities and aggregate dollar amounts shown.

Key Figures

Proposed sale 02/25/2026: 24,000 shares Aggregate amount 02/25/2026: $2,012,076.00 Proposed sale 03/02/2026: 11,340 shares +4 more

7 metrics

Proposed sale 02/25/2026 24,000 shares proposed sale reported on Form 144

Aggregate amount 02/25/2026 $2,012,076.00 aggregate dollar amount paired with 24,000 shares

Proposed sale 03/02/2026 11,340 shares proposed sale reported on Form 144

Aggregate amount 03/02/2026 $974,430.00 aggregate dollar amount paired with 11,340 shares

Proposed sale 04/02/2026 22,680 shares proposed sale reported on Form 144

Aggregate amount 04/02/2026 $1,818,055.00 aggregate dollar amount paired with 22,680 shares

Securities type noted RSU / PSU listed under Securities To Be Sold (05/03/2026)

Key Terms

Form 144, RSU / PSU, Equity Compensation

3 terms

Form 144 regulatory

"The filing lists proposed insider sales under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU / PSU financial

"RSU / PSU - See Remarks listed under Securities To Be Sold"

Equity Compensation financial

"Equity Compensation appears as the transaction type for the securities sold"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	9968	818106.00	575800000	05/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/03/2026	RSU / PSU - See Remarks	EDWARDS LIFESCIENCES CORPORATION			9968	05/03/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DONALD E BOBO JR ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	02/25/2026	24000	2012076.00
DONALD E BOBO JR ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	03/02/2026	11340	974430.00
DONALD E BOBO JR ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	04/02/2026	22680	1818055.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Edwards Lifesciences' (EW) Form 144 disclose?

It discloses proposed insider sales via Form 144 by Donald E. Bobo Jr. The filing lists sale dates of 02/25/2026, 03/02/2026, and 04/02/2026 with respective share counts and aggregate dollar amounts shown in the excerpt.

How many shares did Donald E. Bobo Jr. report for sale on 02/25/2026?

The excerpt shows a proposed sale of 24,000 shares on 02/25/2026 with an aggregate amount of $2,012,076.00 reported alongside that date and quantity in the filing.

What other sale notices are listed in the Form 144 excerpt for EW?

The filing additionally lists proposed disposals of 11,340 shares on 03/02/2026 (aggregate $974,430.00) and 22,680 shares on 04/02/2026 (aggregate $1,818,055.00) by the same reporting person.

Are the securities in the filing described as equity compensation?

Yes. The excerpt identifies the securities as RSU / PSU and lists the transaction type as Equity Compensation with a filing date of 05/03/2026 for the securities to be sold entry.